- Home
- XBIO vs AZI Comparison
XBIO vs AZI Comparison
Compare XBIO & AZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XBIO | AZI |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | China |
| Employees | 2 | 53 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 8.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | XBIO | AZI |
|---|---|---|
| Price | $3.30 | $1.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.9K | ★ 179.7K |
| Earning Date | 05-12-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $0.03 |
| 52 Week High | $13.93 | $4.60 |
Technical Indicators
Market Signals| Indicator | XBIO | AZI |
|---|---|---|
| Relative Strength Index (RSI) | 64.70 | 51.83 |
| Support Level | $3.45 | $1.51 |
| Resistance Level | $3.49 | $4.50 |
| Average True Range (ATR) | 0.20 | 0.21 |
| MACD | 0.04 | -0.06 |
| Stochastic Oscillator | 79.62 | 11.78 |
Price Performance
Historical ComparisonAbout XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, it has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the auto parts & auto accessories sales.